Ablation Catheters Market in Europe 2015-2019
About ablation catheters
Arrhythmia is a condition resulting in an abnormal heartbeat, which occurs due to changes in electrical impulses. The electrical impulses can either be too fast or too slow, resulting in sudden cardiac arrest. Cardiac arrhythmia is one of the leading causes of premature death and is characterized by the abrupt loss of heart function. Cardiac dysfunction results in the inhibition of blood flow to the brain and other vital organs.
In Europe, approximately 11 million people are affected by cardiac arrhythmia, of which 6 million people are affected by atrial fibrillation. An ablation catheter aims to stop the irregular heart beat by removing the abnormal tissue responsible for causing the arrhythmia. It is a minimally invasive procedure usually performed under local anesthesia. The procedure involved one or more flexible catheters threaded through blood vessels into the heart. These catheters record the heart’s electrical activity and identify the tissue responsible for the arrhythmia.
Technavio's analysts forecast the ablation catheters market in Europe to grow at a CAGR of 10.14% over the period 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects of the ablation catheters market in Europe for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of ablation catheters.
Technavio's report, Ablation Catheters Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the ablation catheters market in Europe and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Technavio Announces the Publication of its Research Report – Ablation Catheters Market in Europe 2015-2019
Technavio recognizes the following companies as the key players in the Ablation Catheters Market in Europe: Biosense Webster, Boston Scientific, Medtronic and St. Jude Medical
Other Prominent Vendors in the market are: Advanced Cardiac Therapeutics, Angiodynamics, APT MEDICAL, Atricure, Biotronik, CardioFocus, Covidien, DVx, Edwards Lifesciences, Estech, Hansen Medical, Imricor Medical Systems, Japan lifeline, LEPU MEDICAL, Melys AFSM, MicroPort, Osypka, PLC Medical Systems, Spectranetics and Stereotaxis
Commenting on the report, an analyst from Technavio’s team said: “The ablation catheter industry is focusing on developing innovative catheters and supporting devices that enable physicians to perform ablation surgeries with high accuracy and at a high success rate. The new technologies aim to reduce overall costs and improve efficiency by delivering tailored treatments to patients and improving treatment outcomes. For instance, in 2014, St. Jude Medical received European approval for the next-generation Flexibility Ablation Catheter, an irrigated ablation catheter with a flexible tip. Many other such products are still in various stages of development. Vendors are also conducting observational and performance studies on these devices to identify areas of improvement.”
According to the report, vendors are increasingly focusing on the development of new ablation tools to improve the efficacy of ablation procedures and patient safety. The new procedures are expected to further reduce procedure time. Catheter technologies have advanced tremendously during the past decade, from the simple 4 mm tip radiofrequency catheters to irrigated catheters with multielectrode recordings, shaft visualization, and contact force measurement. Alternatives to radiofrequency-based ablation procedures include cryoenergy-, cryoablation-, and laser-based ablation procedures. Also, electrophysiologists and cardiac surgeons are interested in advanced products that demonstrate better efficiency, improved patient outcomes, and cost-effectiveness. Vendors and researchers are conducting studies on the cost-effectiveness of ablation procedures over antiarrhythmic drugs to showcase the effectiveness of their products and to obtain reimbursement, which will help increase the adoption and sale of their products.
Further, the report states that a lack of trained electrophysiologists is restricting the growth of the market in Europe.
Biosense Webster, Boston Scientific, Medtronic, St. Jude Medical, Advanced Cardiac Therapeutics, Angiodynamics, APT MEDICAL, Atricure, Biotronik, CardioFocus, Covidien, DVx, Edwards Lifesciences, Estech, Hansen Medical, Imricor Medical Systems, Japan lifeline, LEPU MEDICAL, Melys AFSM, MicroPort, Osypka, PLC Medical Systems, Spectranetics, Stereotaxis
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook